Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|3|2|123-131

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.3, Iss.2, 2008-05, pp. : 123-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropsychotherapeutics/tilidine: Elevated cerebrospinal fluid Tau-protein level and memory disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome

By Mai W   Hu X   Lu Z   Peng F   Wang Y  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2402-2413

Field House Publishing

Access to resources Recommend Favorite

Modulation of -amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors

By Hellstrom-Lindahl E.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 255-263

Elsevier

Access to resources Recommend Favorite

Pharmacology of the Intracellular Pathways Activated by Amyloid Beta Protein

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-01 ,pp. : 724-740

Bentham Science Publishers

Access to resources Recommend Favorite

Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 538-546

Bentham Science Publishers

Access to resources Recommend Favorite